Shares of Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) fell 3.9% during trading on Friday . The company traded as low as $51.10 and last traded at $51.10. 717 shares were traded during trading, a decline of 13% from the average session volume of 823 shares. The stock had previously closed at $53.18.
Hikma Pharmaceuticals Price Performance
The stock’s 50-day moving average price is $50.48 and its two-hundred day moving average price is $49.58.
Hikma Pharmaceuticals Cuts Dividend
The firm also recently announced a dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, August 20th will be paid a dividend of $0.62 per share. This represents a dividend yield of 2.98%. The ex-dividend date of this dividend is Monday, August 19th. Hikma Pharmaceuticals’s dividend payout ratio is 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Investing In Preferred Stock vs. Common Stock
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- CD Calculator: Certificate of Deposit Calculator
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- Stock Analyst Ratings and Canadian Analyst Ratings
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
